These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 27826754

  • 1. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
    Rashid MU, Muhammad N, Amin A, Loya A, Hamann U.
    Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
    [Abstract] [Full Text] [Related]

  • 2. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I, Kleibl Z, Stribrna J, Kotlas J, Zimovjanova M, Mateju M, Zikan M, Pohlreich P.
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [Abstract] [Full Text] [Related]

  • 3. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
    Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, Hellebrand H, Goecke TO, Kiechle M, Niederacher D, Schmutzler RK, Meindl A.
    Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
    [Abstract] [Full Text] [Related]

  • 4. Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients-Novel Variants from a Large National Center.
    Bozsik A, Pócza T, Papp J, Vaszkó T, Butz H, Patócs A, Oláh E.
    Int J Mol Sci; 2020 Jun 30; 21(13):. PubMed ID: 32629901
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
    Riahi A, Chabouni-Bouhamed H, Kharrat M.
    Cancer Genet; 2017 Jan 30; 210():22-27. PubMed ID: 28212807
    [Abstract] [Full Text] [Related]

  • 6. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.
    Sluiter MD, van Rensburg EJ.
    Breast Cancer Res Treat; 2011 Jan 30; 125(2):325-49. PubMed ID: 20232141
    [Abstract] [Full Text] [Related]

  • 7. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.
    Vasickova P, Machackova E, Lukesova M, Damborsky J, Horky O, Pavlu H, Kuklova J, Kosinova V, Navratilova M, Foretova L.
    BMC Med Genet; 2007 Jun 11; 8():32. PubMed ID: 17561994
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM, Zheng YB, Gao Y, Ding XW, Sun Y, Huang Y, Lou CJ, Pan ZW, Peng G, Wang XJ.
    BMC Cancer; 2019 Jun 07; 19(1):551. PubMed ID: 31174498
    [Abstract] [Full Text] [Related]

  • 9. Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
    McVeigh TP, Cody N, Carroll C, Duff M, Farrell M, Bradley L, Gallagher D, McDevitt T, Green AJ.
    Cancer Genet; 2017 Aug 07; 214-215():1-8. PubMed ID: 28595730
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer.
    Su L, Zhang J, Meng H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y.
    Clin Genet; 2018 Jul 07; 94(1):165-169. PubMed ID: 29582426
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S, Esteban Cardeñosa E, Barragán González E, Oltra Soler S, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Bolufer Gilabert P, Group for Assessment of Hereditary Cancer of Valencia Community.
    Breast Cancer Res Treat; 2008 Nov 07; 112(1):63-7. PubMed ID: 18060491
    [Abstract] [Full Text] [Related]

  • 14. Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin.
    Ruiz de Garibay G, Gutiérrez-Enríquez S, Garre P, Bonache S, Romero A, Palomo L, Sánchez de Abajo A, Benítez J, Balmaña J, Pérez-Segura P, Díaz-Rubio E, Díez O, Caldés T, de la Hoya M.
    Breast Cancer Res Treat; 2012 May 07; 133(1):273-83. PubMed ID: 22434521
    [Abstract] [Full Text] [Related]

  • 15. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
    Silva FC, Lisboa BC, Figueiredo MC, Torrezan GT, Santos EM, Krepischi AC, Rossi BM, Achatz MI, Carraro DM.
    BMC Med Genet; 2014 May 15; 15():55. PubMed ID: 24884479
    [Abstract] [Full Text] [Related]

  • 16. Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements.
    Fachal L, Blanco A, Santamariña M, Carracedo A, Vega A.
    PLoS One; 2014 May 15; 9(3):e93306. PubMed ID: 24686251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
    Preisler-Adams S, Schönbuchner I, Fiebig B, Welling B, Dworniczak B, Weber BH.
    Cancer Genet Cytogenet; 2006 Jul 01; 168(1):44-9. PubMed ID: 16772120
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A, Louchez MM, Fournier J, Gamoudi A, Rahal K, El May MV, El May A, Revillion F, Peyrat JP.
    Bull Cancer; 2014 Nov 01; 101(11):E36-40. PubMed ID: 25418591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.